RNS Number : 7705S
Burberry Group PLC
17 June 2024
 

Burberry Group plc (the "Company") - Director/PDMR Shareholdings

 

The Company has today been notified of the following transactions by a Director/person discharging managerial responsibilities ("PDMR"):

 

On 17 June 2024, Jonathan Akeroyd, Chief Executive Officer and a director of the Company, received 24,643 ordinary shares of 0.05p each in the Company ("Shares") following the vesting of a conditional award granted to him on 15 March 2022, as part of the buy-out awards he received on joining the Company for forfeiting awards on resignation from his former employer. On vesting of the award, Mr Akeroyd also received 2,736 dividend equivalent Shares giving a total number of Shares acquired of 27,379. This award was granted under the rules of the Burberry Share Plan 2020.

 

Following this acquisition, on 17 June 2024, Mr Akeroyd subsequently sold a total of 12,911 of the newly acquired Shares, at a price of £9.741411 per Share, to fund the tax and fees arising from the vesting and acquisition, as set out below.

 

Director

Number of Shares acquired

Number of Shares sold to cover tax and fees

Number of Shares retained

Jonathan Akeroyd

27,379

12,911

14,468

 

17 June 2024

 

 

The following disclosures are made in accordance with Article 19 of the EU Market Abuse Regulation 596/2014 as it forms part of UK law.

 

Notification of dealing form

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Jonathan Akeroyd

2

Reason for the notification

a)

Position/status

Chief Executive Officer 

b)

Initial notification /Amendment

Initial notification          

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Burberry Group plc

b)

LEI

213800PE1KEFCNFR1R50

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of 0.05 pence each ("Shares")

 

 

GB0031743007

b)

Nature of the transaction

Acquisition of Shares following the vesting of a conditional share award over 24,643 Shares granted on 15 March 2022 under the rules of the Burberry Share Plan 2020, plus 2,736 dividend equivalent Shares.

 

c)

Price(s) and volume(s)

 

Price(s)

Volume(s)

£Nil

 

27,379

 

 

d)

Aggregated information

 

- Aggregated volume

 

- Price

 

 

Aggregate Price

Aggregate Volume

Aggregate

Total

£Nil

 

27,379

£Nil

e)

Date of the transaction

2024-06-17

f)

Place of the transaction

Outside a trading venue

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of 0.05 pence each ("Shares")

 

 

GB0031743007

b)

Nature of the transaction

Sale of Shares

c)

Price(s) and volume(s)

 

Price(s)

Volume(s)

£9.741411

12,911

 

d)

Aggregated information

 

- Aggregated volume

 

- Price

 

 

Aggregate Price

Aggregate Volume

Aggregate

Total

£9.741411

12,911

£125,771.36

e)

Date of the transaction

2024-06-17

 

f)

Place of the transaction

London Stock Exchange (XLON)

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHFLFVRREIDLIS